|

Anti-Diarrheal Agent Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • BeOne Medicines1

Indications

  • Metastatic Breast Cancer1
  • Hormone Receptor Positive Malignant Neoplasm of Breast1
  • Hormone Receptor Positive HER-2 Negative Breast Cancer1
  • Hormone Receptor Positive Breast Carcinoma1
  • HER2-negative Breast Cancer1

Denver, Colorado1 trial

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Sarah Cannon Research Institute (Scri) At Health One

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.